Sequence Bio
Discovering the true signals of disease to power life-changing drugs.
St. John's, Canada · Founded 2013 · $3.9M raised
- Headquarters
- St. John's
- Employees
- 51–200
- Founded
- 2013
- Website
- sequencebio.com
- Total Funding
- $3.9M
- Last Round
- $3.9M SeedAug 2016
- Rounds
- 1
About
90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.
Summary
Sequence Bio is a Drug Discovery company based in St. John's, Canada, founded in 2013. It has raised $3.9M in total across 1 round, most recently a $3.9M Seed round in Aug 2016. Investors include DCVC (Data Collab).
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2016
Investors
Similar Companies
Verve Therapeutics develops gene-editing treatments for atherosclerotic cardiovascular disease us...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sequencebioinformatics"><img src="https://indexed.vc/api/badge/company/sequencebioinformatics" alt="Sequence Bio on Indexed.vc" width="260" height="76" /></a>